Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Immuno-Oncology Therapy for Hepatocellular Carcinoma: Current Status and Ongoing Trials — Masatoshi Kudo (2019) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Immuno-Oncology Therapy for Hepatocellular Carcinoma: Current Status and Ongoing Trials
Shared by
Masatoshi Kudo
Immuno-Oncology Therapy for Hepatocellular Carcinoma: Current Status and Ongoing Trials
Editorial Material
2019
en
Authors
Masatoshi Kudo
Related publications
Article
2017
Immuno-Oncology in Hepatocellular Carcinoma: 2017 Update
Masatoshi Kudo
Article
2017
Immune Checkpoint Inhibition in Hepatocellular Carcinoma: Basics and Ongoing Clinical Trials
Masatoshi Kudo
Article
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
2015
Cone-Beam CT Angiography for Hepatocellular Carcinoma: Current Status
Yasunori Minami
,
Takamichi Murakami
,
Masayuki Kitano
,
Toshiharu Sakurai
,
Naoshi Nishida
,
Masatoshi Kudo
Editorial Material
2016
Molecular Targeted Agents for Hepatocellular Carcinoma: Current Status and Future Perspectives
Masatoshi Kudo
Article
2023
[Management of hepatocellular carcinoma: current status and future perspective].
Masatoshi Kudo
Discussion(0)
No comments yet. Be the first to comment.